Blood was drawn using Li-heparin sample tubes (BD Vacutainer).
HPLC-grade acetonitrile and water for sample dilution and FIA were obtained from Biosolve.
Formic acid and
ammonium formate were purchased from Sigma Aldrich. Solutions for analysis were stored in 1.5 ml glass vials (ALWSCI).
HPLC analysis was performed on a
Waters 2695 Separations Module (Alliance) with a PolyCAT A column (200 × 4,6 mm, 5 μm, Alltech Applied Science BV). Detection was performed by in-line UV-vis detection (
Waters 2487 Dual λ Absorbance Detector) and date was processed using Empower Pro 2. Ingredients for mobile phase A and B for HPLC (40 mM Bis-Tris + 2 mM KCN, pH 6.5 and 40 mM Bis-Tris + 2 mM KCN + 200 mM NaCl, pH 6.8) were obtained from Sigma Aldrich.
DNA analysis for α-thalassemia screening by GAP-PCR was performed on a
Peltier Thermal Cycler (Biorad). Primers for five deletions were applied: 3.7, 4.2, 20.5, SEA and MED, which account for ±80% of α-thalassemia [23] . Quantification was performed by ImaGo Imaging (B&L systems).
UV-vis spectra for determination of the hemoglobin concentration were recorded on a Perkin Elmer Lambda 25.
Mass spectra were acquired from a Waters
Xevo® G2-S Q-ToF with ESI connected to a Aquity
UPLC I-class system. Operation of the setup was conducted with the software package MassLynx.
Helmich F., van Dongen J.L., Kuijper P.H., Scharnhorst V., Brunsveld L, & Broeren M.A. (2016). Rapid phenotype hemoglobin screening by high-resolution mass spectrometry on intact proteins. Clinica chimica acta; international journal of clinical chemistry, 460.